[1]
|
Zucca, E., Conconi, A., Mughal, T.I., et al. (2003) Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the international extranodal lymphoma study group. Journal of Clinical Oncology, 21, 20-27.
doi:10.1200/JCO.2003.11.141
|
[2]
|
Mitropoulous, F.A., Angelopoulou, M.P., Siakantaris, G.R., et al. (2000) Primary non-Hodgkin’s lymphoma of the gallbladder. Leukemia & Lymphoma, 40, 123-131.
|
[3]
|
Repine, T.B., DeArmond, G. and Lopez, J.D. (2004) Burkitt’s lymphoma involving the gallbladder. Journal of Clinical Oncology, 22, 5014-5015.
doi:10.1200/JCO.2004.11.026
|
[4]
|
Minamimoto, R., Senda, M., Terauchi, T., et al. (2010) Analysis of various malignant neoplasm detected by FDG-PET cancer screening program: Based on a Japanese Nationwide Survey. Annals of Nuclear Medicine, 17, 45-54.
|
[5]
|
Michaellet, A.S., Trotman, J. and Tychyl-Pinel, C. (2010) Role of early PET in the management of diffuse large B cell lymphoma. Current Opinion in Oncology, 22, 414-418. doi:10.1097/CCO.0b013e32833d5905
|
[6]
|
Lin, C., Itti, E., Haioun, C., et al. (2007) Early 18F-FDG PET for Prediction of Prognosis in Patients with diffuse large B cell lymphoma: SUV-based assessment versus visual analysis. Journal of Nuclear Medicine, 10, 1626-1632.
|
[7]
|
Ng, A.P., Seymour, J.F., Lee, M., et al. (2007) Early therapeutic response assessment by (18) FDG-positron emission tomography during chemotherapy I patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure. Leukemia & Lymphoma, 48, 596-600. doi:10.1080/10428190601099965
|
[8]
|
Gardini, A., Saragori, L., La Barba, G., et al. (2009) Simultaneous occurrence of primary diffuse large B cell lymphoma and extranodal marginal zone (MALT) B-cell lymphoma in the gallbladder: A case report. Pathologica, 101, 230-234.
|
[9]
|
Mani, H., Climent, F., Colomo, L., et al. (2010) Gall bladder and extra hepatic bile duct lymphomas: Clinicopathological observations and biological implications. Am Journal of Surgical Pathology, 34, 1277-1286.
doi:10.1097/PAS.0b013e3181e9bb8b
|
[10]
|
Schoder, H., Noy, A., Gonen, M., et al. (2005) Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin’s lymphoma. Journal of Clinical Oncology, 23, 4643-4651. doi:10.1200/JCO.2005.12.072
|